Inhibition of camel lens ζ-crystallin by aspirin and aspirin-like analgesics

被引:4
|
作者
Bazzi, MD [1 ]
Rabbani, N [1 ]
Duhaiman, AS [1 ]
机构
[1] King Saud Univ, Coll Sci, Dept Biochem, Riyadh 11451, Saudi Arabia
关键词
camel lens; zeta-crystallin; inhibition; aspirin;
D O I
10.1016/S1357-2725(01)00099-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Camel lens zeta-crystallin was reversibly inhibited to various degrees by aspirin (acetyl salicylic acid) and the aspirin-like analgesics: paracetamol (acetaminophen) and ibuprofen (2-(4-isobutyl phenyl)-propionic acid). Among these. aspirin was the most potent inhibitor. causing nearly complete inhibition in a dose-dependent, but time-independent manner. Analysis of inhibition kinetics revealed that aspirin was uncompetitive inhibitor (K-i 0.64 mM) with respect to NADPH and non-competitive inhibitor (K-i 1.6 mM) with respect to the substrate, 9.10-phenan-threnequinone (PQ). Multiple-inhibition analysis showed that aspirin and pyridoxal 5' phosphate (PAL-P), a lysine specific reagent. simultaneously bound to a critical lysine residue located towards the NADPH binding region. Consistent with this. NADPH was able to substantially protect zeta-crystallin against aspirin. whereas PQ did not provide any protection. The results suggested that an essential lysine residue was the locus of aspirin binding. The inhibition of zeta-crystallin by aspirin and aspirin-like analgesics was reversible thus eliminating acetylation as a mechanism for inhibition. Reversible binding of aspirin to this lysine may cause steric hindrance resulting in uncompetitive inhibition with respect to NADPH. (C) 2001 Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:70 / 77
页数:8
相关论文
共 50 条
  • [31] Aspirin-like defect in pregnancy and delivery: a case report
    Lopez-Munoz, N.
    Castro Quismondo, N.
    THROMBOSIS RESEARCH, 2019, 175 : S21 - S21
  • [32] Clinical and laboratory phenotype associated with the aspirin-like defect
    Dragani, Alfredo
    Brancati, Francesco
    Pascale, Silvia
    Mattoscio, Domenico
    Rocca, Bianca
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 148 (04) : 661 - 663
  • [33] A chelate theory for the mechanism of action of aspirin-like drugs
    Wang, X
    MEDICAL HYPOTHESES, 1998, 50 (03) : 239 - 251
  • [34] PATHOPHYSIOLOGIC ROLES OF PROSTAGLANDINS AND ACTION OF ASPIRIN-LIKE DRUGS
    NAKANO, J
    KOSS, MC
    SOUTHERN MEDICAL JOURNAL, 1973, 66 (06) : 709 - 723
  • [35] Inhibition of Antiplatelet Effects of Aspirin by Nonopioid Analgesics
    Hohlfeld, T.
    Schroer, K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 (02) : 131 - 134
  • [36] THE REACTION OF BOVINE LENS ALPHA-A-CRYSTALLIN WITH ASPIRIN
    HASAN, A
    SMITH, JB
    QIN, W
    SMITH, DL
    EXPERIMENTAL EYE RESEARCH, 1993, 57 (01) : 29 - 35
  • [37] INHIBITION OF PROSTAGLANDIN BIOSYNTHESIS AS MECHANISM OF ANALGESIA OF ASPIRIN-LIKE DRUGS IN DOG KNEE-JOINT
    MONCADA, S
    FERREIRA, SH
    VANE, JR
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1975, 31 (02) : 250 - 260
  • [38] FURTHER EXPERIMENTS TO ESTABLISH THAT ANALGESIC ACTION OF ASPIRIN-LIKE DRUGS DEPENDS ON INHIBITION OF PROSTAGLANDIN BIOSYNTHESIS
    FERREIRA, SH
    MONCADA, S
    VANE, JR
    BRITISH JOURNAL OF PHARMACOLOGY, 1973, 47 (03) : P629 - P630
  • [39] A STUDY OF ASPIRIN-LIKE COMPOUNDS ON THE RAT PLEURISY MODEL OF INFLAMMATION
    KILLACKEY, BA
    KILLACKEY, JJ
    PHILP, RB
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1982, 4 (04): : 353 - 353
  • [40] Aspirin-like molecules that covalently inactivate cyclooxygenase-2
    Kalgutkar, AS
    Crews, BC
    Rowlinson, SW
    Garner, C
    Seibert, K
    Marnett, LJ
    SCIENCE, 1998, 280 (5367) : 1268 - 1270